Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $4.0M | $10.1M | $35.8M | $68.0M | $87.1M |
| Cost of revenue | $3.0M | $4.6M | $21.4M | $39.2M | $43.8M |
| Gross profit | $963.4K | $5.5M | $14.4M | $28.8M | $43.3M |
| Gross margin | 24.0% | 54.4% | 40.2% | 42.3% | 49.7% |
| R&D | $2.8M | $3.2M | $4.7M | $9.5M | $10.5M |
| Operating income | −$9.7M | −$11.8M | −$20.1M | −$26.6M | −$26.0M |
| EBITDA | −$9.6M | −$10.9M | −$17.3M | −$249.2M | −$21.3M |
| Net income | −$10.1M | −$12.0M | −$20.2M | −$251.4M | −$26.0M |
| Net margin | -251.3% | -119.4% | -56.5% | -369.4% | -29.8% |
| EPS (diluted) | -0.16 | -0.19 | -0.31 | -4.48 | -0.39 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds DLHTF.
No tracked institution reports a position in DLHTF as of their last filing.
No one on the platform has traded DLHTF yet.
| $281M |
| — |
| HTLZFHamilton Thorne Ltd. | $1.59 | — | $245M | — |
| NWPHFNewron Pharmaceuticals S.p.A. | $20.00 | +0.00% | $416M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Dialogue Health Tech ( $CARE.CA ) social hype OVER HYPED. Current probability of distress is under 40% https://www.macroaxis.com/stock/CARE.TO/Dialogue-Health-Technologies #canada #canadian_equities #CA
View on StockTwits ↗Dialogue Health Technologies's PT raised by CIBC to C$5.15. www.marketbeat.com/stocks/TSE/CARE/price-target/ $CARE.CA
View on StockTwits ↗Dialogue Health Technologies downgraded by TD Securities to tender. C$5.15 PT. www.marketbeat.com/stocks/TSE/CARE/price-target/ $CARE.CA
View on StockTwits ↗$CARE.TO sooooo, this is $100MM and 10% YOY growth. This sustains it’s current SP, eh? DOC.ca is $110MM and will be EBITDA positive in 2023 and is growing a a similar clip. DOC is 17c/share So, either CARE is over valued or………
View on StockTwits ↗$CARE.TO Buying a little bit here today in 2.30s. Kinda volatile and illiquid though so not too large, just a fun size as we are in a demand zone
View on StockTwits ↗$CARE.TO Why is this trading so low lately? Was there any catalyst or it's just general lack of buying?
View on StockTwits ↗$CARE.TO https://ca.finance.yahoo.com/news/scotiabank-selects-dialogue-health-technologies-120000773.html
View on StockTwits ↗$CARE.TO how necessary is it that u knell and become CloudMD? I’ll wait
View on StockTwits ↗$CARE.TO Finally some life on this one! Let’s push toward ATH. Currently SP make no sense. Way undervalued.
View on StockTwits ↗$CARE.TO https://www.newswire.ca/news-releases/dialogue-health-technologies-and-sun-life-expand-partnership-to-include-eap-and-icbt-864102886.html
View on StockTwits ↗@Charlybaby wrong. DOC has it all as one patented and fully integrated whole patient $CARE.TO is only partial. Fact
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.